ADAMTS-13 levels in patients with a history of thrombotic thrombocytopenic purpura.

Withdrawn

• Conditions: thrombotische thrombocytopenic purpura; 10018849

• Registration Number: NL-OMON29947
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 13 May 2024

Recruitment & Eligibility

• Status: Withdrawn
• Sex: Not specified
• Target Recruitment: 50

Inclusion Criteria

Patients with a history of thrombotic thrombocytopenic purpura. Patients are approched by the

Exclusion Criteria

None

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>End point: determination of the ADAMTS-13 activity in blood and the relation<br /><br>with relapsing TTP. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>not applicable</p><br>